All medicines undergo clinical trials to assess their safety, quality and effectiveness. Most tests use adults; fewer than 50% of children’s medicines have actually been tested in children. A new European regulation that aims to increase the development and testing of medicines specifically for use in children will become law in the UK by the end of 2006. This note examines current and future regulation of research into, and clinical trials of, children’s medicines and discusses the issues raised.